While venture capitalists have been dialing back on potentially risky early stage investments, translational researchers have been marching ahead. Government funding is pushing new discoveries forward, but sometimes the best of these languish in academic labs where companies and more adventurous investors are less likely to discover them. This year the Neurotech Development Foundation (NDF), a new nonprofit founded to promote the advancement of translational neuroscience research, and several institutes at the NIH (including NINDS, NIMH, and NIA) teamed up to find and showcase the most promising work to Neurotech 2010 attendees in Boston on May 20, 2010. We've just posted the full article here which highlights the breakthrough translational work of the researchers selected for the session.